MORABITO, GABRIELLA
MORABITO, GABRIELLA
DIPARTIMENTO DI STATISTICA E METODI QUANTITATIVI
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
2024 Morabito, G; Gregorio, C; Ieva, F; Barbati, G; Mancia, G; Corrao, G; Rea, F
The COVID-19 Pandemic Was Associated with a Change in Therapeutic Management and Mortality in Heart Failure Patients
2024 Ponzoni, M; Morabito, G; Corrao, G; Gerosa, G; Cantarutti, A; Rea, F
The hazard of using the Poisson model to cope with immortal time bias in the case of time-varying hazard
2024 Rea, F; Morabito, G; Corrao, G; Cantarutti, A
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study
2024 Ciardullo, S; Morabito, G; Rea, F; Savaré, L; Perseghin, G; Corrao, G
Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy
2023 Rea, F; Morabito, G; Savare, L; Pathak, A; Corrao, G; Mancia, G
THE IMPACT OF RENAL DENERVATION PROCEDURE ON THE USE OF ANTIHYPERTENSIVE DRUGS. A REAL-LIFE INVESTIGATION FROM ITALY
2023 Rea, F; Morabito, G; Savare, L; Corrao, G; Mancia, G
TREATMENT STRATEGIES AND ADHERENCE TO THE TRIPLE COMBINATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, A CALCIUM-CHANNEL BLOCKER, AND A DIURETIC
2023 Rea, F; Morabito, G; Savaré, L; Pathak, A; Corrao, G; Mancia, G
TREATMENT STRATEGIES AND ADHERENCE TO THE TRIPLE COMBINATION OF AN ANGIOTENSINCONVERTING ENZYME INHIBITOR, A CALCIUMCHANNEL BLOCKER, AND A DIURETIC
2023 Rea, F; Morabito, G; Savare, L; Corrao, G; Mancia, G
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study
2022 Ciardullo, S; Rea, F; Savaré, L; Morabito, G; Perseghin, G; Corrao, G
The impact of renal denervation procedure on use of antihypertensive drugs in the real-life setting
2022 Rea, F; Morabito, G; Savaré, L; Corrao, G; Mancia, G